Jazz pharma buy out Redx in the future10 Feb 2024 10:52
Why did jazz not just buyout Redx - because they are leveraging the upside for very little cost. They are more than capable of buying out Redx as they have done much larger buyouts in the past. Let’s be honest they won’t pay Redx 870million, imo, they would be nuts too, they are setting them up for a future buyout. Let’s say they could buy them for 3/400 million they would still be winners BUT Redx must have known that - so why agree? - it’s a win win for them also as the collaboration with Jazz will hopefully bring the Kraz inhibitor programme to fruition at a much faster pace and also reduces cost to Redx. But what if another pharmaceutical company was in the mix too, we are already collaborating with the likes of Astra Zenica, others will have picked up on this deal, Redx have a lot more in development than just Kraz programme and it then becomes a much more interesting scenario.
Would be interested to hear others thoughts. This is all IMO but see interesting times ahead for Redx .